文献速递糖尿病

多学科风险评估与管理计划-糖尿病(RAMP-DM)对心血管及微血管并发症和全因死亡率的十年有效性:一项基于人群的队列研究

Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study.
PubMed 文献 · Diabetes Care · 2022-01-01

该研究基于香港公共基层医疗系统2009至2010年管理的成人2型糖尿病患者,采用倾向性评分1:1匹配RAMP-DM参与者与常规照护患者并随访10年。共纳入36,746例(每组18,373例),中位随访9.5年。RAMP-DM组大血管并发症(HR 0.52,95%CI 0.50-0.54)、微血管并发症(HR 0.68,95%CI 0.64-0.72)及全因死亡率(HR 0.45,95%CI 0.43-0.47)风险均显著低于仅接受常规照护的患者,但并发症预防效应分别在第9年和第8年后减弱。

要点

  • RAMP-DM组大血管并发症风险显著低于常规照护组(HR 0.52,95%CI 0.50-0.54)。
  • RAMP-DM组微血管并发症风险显著低于常规照护组(HR 0.68,95%CI 0.64-0.72)。
  • RAMP-DM组全因死亡率显著低于常规照护组(HR 0.45,95%CI 0.43-0.47),但并发症预防效应在随访8年后减弱。

核心结论

  • 在10年随访中,RAMP-DM参与者糖尿病相关并发症和全因死亡率显著降低,但并发症预防效应在8年后减弱。

研究设计与样本

  • 基于人群的前瞻性队列研究,纳入2009至2010年香港公共基层医疗系统管理的成人2型糖尿病患者,RAMP-DM参与者与常规照护患者按1:1倾向性评分匹配并随访10年。
  • 匹配后共纳入36,746例患者(每组18,373例),中位随访9.5年,共306,802人年。

主要发现

  • RAMP-DM组大血管并发症风险显著低于常规照护组(HR 0.52,95%CI 0.50-0.54)。
  • RAMP-DM组微血管并发症风险显著低于常规照护组(HR 0.68,95%CI 0.64-0.72)。
  • RAMP-DM组全因死亡率显著低于常规照护组(HR 0.45,95%CI 0.43-0.47)。
  • RAMP-DM对大血管和微血管并发症的效应分别在随访第9年和第8年后减弱。
  • RAMP-DM参与者血红蛋白A1c、血压、甘油三酯和BMI控制更好,肾功能下降更慢。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) is a protocol-driven, risk-stratified, and individualized management program offered by a multidisciplinary team in addition to usual care for primary care patients with diabetes. This study aimed to evaluate the effectiveness of RAMP-DM for preventing complications and mortality over 10 years. RESEARCH DESIGN AND METHODS: A population-based, prospective cohort study of adult patients with type 2 diabetes managed in the Hong Kong public primary health care system between 2009 and 2010 was conducted. RAMP-DM participants and usual care patients were matched using one-to-one propensity score matching and followed for 10 years. Risks of macrovascular and microvascular complications and all-cause mortality were estimated by Cox proportional hazards regression. RESULTS: A total of 36,746 patients (18,373 in each group) were included after propensity score matching, with a median follow-up of 9.5 years and 306,802 person-years. RAMP-DM participants had significantly lower risks of macrovascular (hazard ratio [HR] 0.52, 95% CI 0.50-0.54) and microvascular (HR 0.68, 95% CI 0.64-0.72) complications and all-cause mortality (HR 0.45, 95% CI 0.43-0.47) than patients who received usual care only. However, the effect of RAMP-DM on macrovascular and microvascular complications attenuated after the 9th and 8th year of follow-up, respectively. RAMP-DM participants also showed better control of hemoglobin A1c, blood pressure, triglycerides, and BMI and a slower decline in renal function. CONCLUSIONS: Significant reductions in diabetes-related complications and all-cause mortality were observed among RAMP-DM participants over a 10-year follow-up, yet the effect of preventing complications attenuated after 8 years.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Tang EHM, Mak IL, Tse ETY, et al. Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study. Diabetes Care. 2022. PMID: 35972235. doi:10.2337/dc22-0387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。